Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 4.60% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.36
Flat results in Sep 25
Risky - Negative EBITDA
Underperformed the market in the last 1 year
Stock DNA
Trading & Distributors
INR 28 Cr (Micro Cap)
565.00
10
0.00%
-0.03
0.16%
0.93
Total Returns (Price + Dividend) 
Nirav Commercial for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Nirav Commercials Faces Intense Selling Pressure Amid Market Volatility
Nirav Commercials Ltd has encountered a day marked by exclusive selling activity, with no buyers recorded in the queue, signalling pronounced distress selling. This development comes amid a backdrop of underperformance relative to the broader market indices and sector peers, raising concerns about the stock’s near-term outlook.
Read More
Nirav Commercials Faces Intense Selling Pressure Amidst Market Downturn
Nirav Commercials Ltd has encountered significant selling pressure today, with the stock registering a sharp decline and exhibiting a rare scenario of exclusively sell orders in the queue. This extreme market behaviour signals distress selling and highlights the challenges faced by the company amid broader market fluctuations.
Read More
Nirav Commercials Faces Intense Selling Pressure Amid Lower Circuit Lock
Nirav Commercials Ltd has encountered a day marked by extreme selling pressure, with the stock hitting a lower circuit and registering only sell orders in the queue. This unusual trading pattern signals distress selling and a lack of buyer interest, raising concerns about the stock’s near-term outlook despite its historical performance.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
12-Nov-2025 | Source : BSENewspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th September 2025
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today On Monday 10Th November 2025:
10-Nov-2025 | Source : BSEThis is to inform you that pursuant to Regulation 30 and Regulation 33 of the Listing Regulations the Board of Directors at its meeting held today i.e. on Monday 10th November 2025 considered and approved the Un-Audited Financial Results for the quarter and half year ended 30th September 2025 along with the Limited Review Report of the auditors thereon
Financials Results For The Quarter And Half Year Ended 30Th September 2025
10-Nov-2025 | Source : BSEThis is to inform you that pursuant to Regulation 30 and Regulation 33 of the Listing Regulations the Board of Directors at its meeting held today i.e. on Monday 10th November 2025 has considered and approved the Un-Audited Financial Results for the quarter and half year ended 30th September 2025 along with the Limited Review Report of the auditors thereon
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Raghav Daga (14.18%)
Judicious Consultants Pvt. Ltd. (9.58%)
7.41%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -23.61% vs -23.40% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 188.89% vs -145.00% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 8.55% vs -22.13% in Sep 2024
Growth in half year ended Sep 2025 is -133.33% vs -95.24% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 2.25% vs 23.30% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -125.00% vs -20.00% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -7.51% vs 9.36% in Mar 2024
YoY Growth in year ended Mar 2025 is -84.38% vs -52.24% in Mar 2024






